Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vascular disease
Phenotype C0035078|renal failure
Sentences 29
PubMedID- 19926968 Hyperfibrinolysis, upa/supar system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment.
PubMedID- 22859794 As previously reported [26], the two groups were well matched for all baseline characteristics, including age, gender, end-stage renal failure cause, presence of cardiovascular disease, body mass index, initial dialysis modality, prescribed medications, blood pressure, prescribed dialysate volumes and glucose exposure, residual renal function and urine volume and laboratory parameters (serum albumin, calcium and haemoglobin).
PubMedID- 21258578 The history of renal pathology is plagued by controversy, and nowhere is this more evident than in the development of cardiovascular disease in patients with chronic renal failure.
PubMedID- 20725646 The prevalence of cardiovascular disease in patients with renal failure is extremely high and accounts for a large part of the morbidity and mortality.
PubMedID- 20497213 Recent advances in ages and rage measurements led us to be capable of understanding more about the role of ages/rage axis as a risk for cardiovascular diseases in patients with renal failure.
PubMedID- 23272852 After transplantation, steroids and calcineurin inhibitors together with end-stage renal failure may lead to associated cardiovascular diseases, particularly in long-term survivors.
PubMedID- 21558176 Bilateral renovascular disease with cardiorenal failure: intervene early or watch and wait.
PubMedID- 24556317 The advantage, however, is the ability to assess vascular disease in patients with severe renal failure without the added risks of gadolinium contrast media.
PubMedID- 22645601 We also reported a close relationship between lower serum sulfatide concentrations and higher incidences of cardiovascular disease in patients with end-stage renal failure [6], in whom sulfatide levels returned to normal following kidney transplantation [7].
PubMedID- 25577237 But other findings showed that hyperhomocysteinemia is a predictor of cardiovascular disease in patients with renal failure as well as chronic stable renal transplant recipients independently of renal function and this is contradictory to the assumption that hyperhomocysteinemia is caused by renal dysfunction [2].
PubMedID- 25393017 Advanced glycation end products (ages) are thought to contribute to the abnormal lipoprotein profiles and increased risk of cardiovascular disease in patients with diabetes and renal failure.
PubMedID- 20144075 The endothelin-1 (et-1) system has been implicated in cardiovascular disease associated with chronic renal failure.
PubMedID- 23555784 In addition to threatening renal function, atherosclerotic renovascular disease (ard) with renal failure poses a risk for exacerbation of cardiovascular disease and predicts cardiovascular mortality [3]–[4].
PubMedID- 22490583 Patients with diabetes mellitus, hypertension, renal failure, history of cardiovascular or cerebrovascular disease were excluded.
PubMedID- 22649481 Diabetes-specific microvascular disease leads to blindness, renal failure and nerve damage, and diabetes-accelerated atherosclerosis which increase risk of myocardial infarction, stroke, and limb amputation [1].
PubMedID- 24465926 From this perspective, adrenomedullin can be considered as a marker of stress in cardiovascular disease, and particularly in patients with renal failure who have all the above mentioned features.
PubMedID- 23162281 Reversible dialysis-dependent renal failure due to undiagnosed renovascular disease.
PubMedID- 23594676 Elevated serum phosphate and fibroblast growth factor 23 (fgf23) levels are associated with cardiovascular disease (cvd) in patients with chronic renal failure (crf).
PubMedID- 26243848 Hypertension, diabetes mellitus, coronary artery disease, chronic heart failure, chronic obstructive pulmonary disease, chronic renal failure, sequel of cerebrovascular disease, rheumatoid arthritis, osteoporosis, and cataract was defined as a chronic disease.
PubMedID- 23250998 renal failure, alcoholic cirrhosis of the liver, cardiovascular diseases and dm were listed as the main causes of death on the death certificate in those patients whose death was attributed to a cause other than tb (table 5).
PubMedID- 24089668 Furthermore, there is a lack of studies evaluating apelin on cardiovascular disease in patients with underlying renal failure.
PubMedID- 22099211 In addition, a poor prognosis, including increased cardiovascular disease mortality, is associated with renal failure in chronic diseases [28-31].
PubMedID- 24587308 In addition to threatening renal function, aras-induced atherosclerotic renovascular disease with renal failure and can result in mortality [3]–[6].
PubMedID- 23697612 Cardiovascular diseases, blindness, renal failure and limb amputations are responsible for frequent hospitalizations and disabilities, resulting in high economic cost for patients and payers[1].
PubMedID- 19934091 A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure.
PubMedID- 25340230 In severe cases poor blood flow to the kidneys leads to acute renal failure and in patients with underlying vascular disease to stroke or myocardial infarction.
PubMedID- 25120290 The huge amount which is being spent on diabetes can be brought down by preventing patients from progressing to stage iii chronic kidney disease and also to end-stage renal failure with postevent cardiovascular disease.
PubMedID- 22382221 Reactive oxygen species are implicated in cardiovascular disease in patients with chronic renal failure (crf).
PubMedID- 21205494 The causes were: infections (36%), chronic renal failure (27%), acute complications of dm (8%) and cardiovascular disease (11%).

Page: 1